Federal contract award
HHSN272201400005C
IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541711 |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $37.2M |
| Current contract value | $37.2M |
| Potential contract value / ceiling | $86.8M |
| Start date | Jan 9, 2014 |
| Current end date | Aug 31, 2022 |
| Potential end date | Aug 31, 2022 |
| Latest award activity | Aug 26, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 36 of 36 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 26, 2026 | P00035 | $-74.3K | TO ADMINISTRATE DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| Sep 23, 2025 | P00034 | $-462.6K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Sep 3, 2025 | P00033 | $-158.3K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Sep 20, 2024 | P00032 | $-70.8K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Aug 31, 2022 | P00030 | $-131.8K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Aug 31, 2022 | P00031 | $-72.7K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Jan 5, 2022 | P00028 | $0 | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FOR OPTION 12B/12BEA EA, 12C EA, 12C, 16G EA AND UPDATE VARIOUS ARTICLES AND CLAUSES. |
| Jan 5, 2022 | P00029 | $0 | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Mar 31, 2021 | P00027 | $-0 | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Mar 30, 2021 | P00026 | $171.1K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Jan 26, 2021 | P00025 | $0 | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Sep 4, 2020 | P00024 | $0 | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Jun 16, 2020 | P00023 | $946.2K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Jun 2, 2020 | P00022 | $151.2K | COVID-19; NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| May 22, 2020 | P00021 | $1.1M | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Apr 9, 2020 | P00020 | $616.1K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Mar 18, 2020 | P00019 | $3.7M | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Aug 1, 2019 | P00018 | $858.3K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Jul 2, 2019 | P00017 | $1.0M | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| May 29, 2019 | P00016 | $559.2K | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| May 2, 2019 | P00015 | $-223.0K | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). |
| Mar 28, 2019 | P00014 | $3.2M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION 5 AND UPDATE CLAUSES. |
| Sep 14, 2018 | 13 | $5.4M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTIONS, REVISE NON-SEVERABLE OPTION END DATES, MAKE EQUITABLE ADJUSTMENTS, AND UPDATE VARIOUS CLAUSES AND ARTICLES. |
| Mar 28, 2018 | 12 | $3.1M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION 4, REMOVE THE FISMA REQUIREMENTS OF ARTICLES H.19 AND H.20, UPDATE NEW CONTRACTING OFFICERS REPRESENTATIVE (COR), CHANGE PRINCIPAL INVESTIGATOR AND TO UPDATE VARIOUS ARTICLES IN THE CONTRACT. |
| Oct 2, 2017 | 11 | $0 | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Aug 1, 2017 | 10 | $1.6M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Mar 14, 2017 | 8 | $0 | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Mar 14, 2017 | 9 | $3.1M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Sep 23, 2016 | 7 | $799.8K | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Sep 12, 2016 | 6 | $644.0K | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Mar 15, 2016 | 5 | $3.0M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Mar 4, 2016 | 4 | $0 | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Aug 31, 2015 | 3 | $935.4K | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Mar 18, 2015 | 2 | $3.0M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Sep 15, 2014 | 1 | $1.2M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Jan 9, 2014 | 0 | $3.0M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.